全文获取类型
收费全文 | 12909篇 |
免费 | 1254篇 |
国内免费 | 154篇 |
出版年
2022年 | 129篇 |
2021年 | 232篇 |
2020年 | 128篇 |
2019年 | 176篇 |
2018年 | 204篇 |
2017年 | 206篇 |
2016年 | 321篇 |
2015年 | 512篇 |
2014年 | 578篇 |
2013年 | 682篇 |
2012年 | 934篇 |
2011年 | 912篇 |
2010年 | 615篇 |
2009年 | 531篇 |
2008年 | 767篇 |
2007年 | 774篇 |
2006年 | 698篇 |
2005年 | 712篇 |
2004年 | 693篇 |
2003年 | 690篇 |
2002年 | 706篇 |
2001年 | 152篇 |
2000年 | 121篇 |
1999年 | 157篇 |
1998年 | 207篇 |
1997年 | 153篇 |
1996年 | 130篇 |
1995年 | 129篇 |
1994年 | 126篇 |
1993年 | 118篇 |
1992年 | 100篇 |
1991年 | 102篇 |
1990年 | 91篇 |
1989年 | 94篇 |
1988年 | 84篇 |
1987年 | 81篇 |
1986年 | 84篇 |
1985年 | 78篇 |
1984年 | 96篇 |
1983年 | 90篇 |
1982年 | 105篇 |
1981年 | 119篇 |
1980年 | 110篇 |
1979年 | 74篇 |
1978年 | 68篇 |
1977年 | 54篇 |
1976年 | 62篇 |
1975年 | 44篇 |
1974年 | 56篇 |
1973年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
981.
Christian Dejaco Bastian Oppl Paul Monach David Cuthbertson Simon Carette Gary Hoffman Nader Khalidi Curry Koening Carol Langford Kathleen McKinnon-Maksimowicz Philip Seo Ulrich Specks Steven Ytterberg Peter A. Merkel Jochen Zwerina 《PloS one》2015,10(3)
Introduction
Previous studies suggest a role for eotaxin-3, TARC/CCL17 and IgG4 in newly- diagnosed patients with eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss) with highly active disease. The role of these biomarkers in relapsing disease is unclear.Methods
Serum levels of TARC/CCL17, eotaxin-3, IgG4, and IgG4/IgG ratio were determined in serum samples from a longitudinal cohort of patients with EGPA (105 visits of 25 patients). Epidemiological, clinical and laboratory data were available for all visits.Results
At the first visit, 80% of patients were using glucocorticoids and 68% additional immunosuppressive drugs. Disease flares were seen at 18 visits. The median BVAS and BVAS/WG scores at time of relapse were 4 and 2, respectively. None of the biomarkers tested were useful to discriminate between active disease and remission. Patients treated with prednisone had lower eotaxin-3 and eosinophil levels compared to patients not taking glucocorticoids irrespective of disease activity. Use of immunosuppressive agents was not associated with biomarker levels.Conclusions
Serum levels of TARC/CCL17, eotaxin-3, IgG4, and IgG4/IgG ratio do not clearly differentiate active and inactive disease in established EGPA. Defining biomarkers in EGPA remains a challenge especially during times of glucocorticoid use. 相似文献982.
Blunted suppression of acyl‐ghrelin in response to fructose ingestion in obese adolescents: The role of insulin resistance
下载免费PDF全文
![点击此处可从《Obesity (Silver Spring, Md.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
983.
William D. Pearse Mark W. Chase Michael J. Crawley Konrad Dolphin Michael F. Fay Jeffrey A. Joseph Gary Powney Chris D. Preston Giovanni Rapacciuolo David B. Roy Andy Purvis 《PloS one》2015,10(5)
Conservation biologists have only finite resources, and so must prioritise some species over others. The EDGE-listing approach ranks species according to their combined evolutionary distinctiveness and degree of threat, but ignores the uncertainty surrounding both threat and evolutionary distinctiveness. We develop a new family of measures for species, which we name EDAM, that incorporates evolutionary distinctiveness, the magnitude of decline, and the accuracy with which decline can be predicted. Further, we show how the method can be extended to explore phyogenetic uncertainty. Using the vascular plants of Britain as a case study, we find that the various EDAM measures emphasise different species and parts of Britain, and that phylogenetic uncertainty can strongly affect the prioritisation scores of some species. 相似文献
984.
985.
Cordelia Ziraldo Alexey Solovyev Ana Allegretti Shilpa Krishnan M. Kristi Henzel Gwendolyn A. Sowa David Brienza Gary An Qi Mi Yoram Vodovotz 《PLoS computational biology》2015,11(6)
People with spinal cord injury (SCI) are predisposed to pressure ulcers (PU). PU remain a significant burden in cost of care and quality of life despite improved mechanistic understanding and advanced interventions. An agent-based model (ABM) of ischemia/reperfusion-induced inflammation and PU (the PUABM) was created, calibrated to serial images of post-SCI PU, and used to investigate potential treatments in silico. Tissue-level features of the PUABM recapitulated visual patterns of ulcer formation in individuals with SCI. These morphological features, along with simulated cell counts and mediator concentrations, suggested that the influence of inflammatory dynamics caused simulations to be committed to “better” vs. “worse” outcomes by 4 days of simulated time and prior to ulcer formation. Sensitivity analysis of model parameters suggested that increasing oxygen availability would reduce PU incidence. Using the PUABM, in silico trials of anti-inflammatory treatments such as corticosteroids and a neutralizing antibody targeted at Damage-Associated Molecular Pattern molecules (DAMPs) suggested that, at best, early application at a sufficiently high dose could attenuate local inflammation and reduce pressure-associated tissue damage, but could not reduce PU incidence. The PUABM thus shows promise as an adjunct for mechanistic understanding, diagnosis, and design of therapies in the setting of PU. 相似文献
986.
987.
The past year has marked the most devastating Ebola outbreak the world has ever witnessed, with over 28,000 cases and over 11,000 deaths. Ebola virus (EBOV) has now been around for almost 50 years. In this review, we discuss past and present outbreaks of EBOV and how those variants evolved over time. We explore and discuss selective pressures that drive the evolution of different Ebola variants, and how they may modify the efficacy of therapeutic treatments and vaccines currently being developed. Finally, given the unprecedented size and spread of the outbreak, as well as the extended period of replication in human hosts, specific attention is given to the 2014–2015 West African outbreak variant (Makona). 相似文献
988.
989.
990.
Sanaz Gabery Nellie Georgiou-Karistianis Sofia Hult Lundh Rachel Y. Cheong Andrew Churchyard Phyllis Chua Julie C. Stout Gary F. Egan Deniz Kirik ?sa Petersén 《PloS one》2015,10(2)
Huntington disease (HD) is a fatal neurodegenerative disorder caused by an expanded CAG repeat in the huntingtin gene. Non-motor symptoms and signs such as psychiatric disturbances, sleep problems and metabolic dysfunction are part of the disease manifestation. These aspects may relate to changes in the hypothalamus, an area of the brain involved in the regulation of emotion, sleep and metabolism. Neuropathological and imaging studies using both voxel-based morphometry (VBM) of magnetic resonance imaging (MRI) as well as positron emission tomography (PET) have demonstrated pathological changes in the hypothalamic region during early stages in symptomatic HD. In this investigation, we aimed to establish a robust method for measurements of the hypothalamic volume in MRI in order to determine whether the hypothalamic dysfunction in HD is associated with the volume of this region. Using T1-weighted imaging, we describe a reproducible delineation procedure to estimate the hypothalamic volume which was based on the same landmarks used in histologically processed postmortem hypothalamic tissue. Participants included 36 prodromal HD (pre-HD), 33 symptomatic HD (symp-HD) and 33 control participants who underwent MRI scanning at baseline and 18 months follow-up as part of the IMAGE-HD study. We found no evidence of cross-sectional or longitudinal changes between groups in hypothalamic volume. Our results suggest that hypothalamic pathology in HD is not associated with volume changes. 相似文献